Polarized α-synuclein trafficking and transcytosis across Brain Endothelial Cells via Rab7-decorated carriers

Abstract

Parkinsons disease is mainly caused by aggregation of -synuclein (-syn) in the brain. Exchange of -syn between the brain and peripheral tissues could have important pathophysiological and therapeutic implications, but the trafficking mechanism of -syn across the blood brain barrier (BBB) remains unclear. In this study, we therefore investigated uptake and transport mechanisms of -syn monomers and oligomers across an in vitro BBB model system. Both -syn monomers and oligomers were internalized by primary brain endothelial cells, with increased restriction of oligomeric over monomeric transport. To enlighten the trafficking route of monomeric -syn in brain endothelial cells, we investigated co-localization of -syn and intracellular markers of vesicular transport. Here, we observed the highest colocalization with clathrin, Rab7 and VPS35, suggesting a clathrin-dependent internalization, preferentially followed by a late endosome retromer-connected trafficking pathway. Furthermore, STED microscopy revealed monomeric -syn trafficking via Rab7-decorated carriers. Knockdown of Caveolin1, VPS35, and Rab7 using siRNA did not affect monomeric -syn uptake into endothelial cells. However, it significantly reduced transcytosis of monomeric -syn in the luminal-abluminal direction, suggesting a polarized regulation of monomeric -syn vesicular transport. Our findings suggest a direct role for Rab7 in polarized trafficking of monomeric -syn across BBB endothelium, and the potential of Rab7 directed trafficking to constitute a target pathway for new therapeutic strategies against Parkinsons disease and related synucleinopathies. Significance StatementIn the submitted manuscript, we describe the use of a state-of-the-art porcine blood-brain barrier model based on primary cells to get information about this important issue. We identify several hitherto undescribed cellular pathways to mediate polarized transport of alpha-synuclein. One of these paths we find regulated by Rab7 and can be inhibited by targeting several intracellular proteins such as VPS35, Caveolin1 and Rab7. New knowledge describing brain endothelial intracellular transport systems are highly warranted for identifying new target to alleviate Parkinsons disease. We believe that our findings could be the seed to establish new therapeutic strategies against Parkinsons disease and related synucleinopathies.